Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
65,881,982
-
Number of holders
-
37
-
Total 13F shares, excl. options
-
1,594,528
-
Shares change
-
+25,630
-
Total reported value, excl. options
-
$8,689,000
-
Value change
-
+$49,086
-
Put/Call ratio
-
178%
-
Number of buys
-
17
-
Number of sells
-
12
-
Price
-
$5.45
Institutional Holders of Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) as of Q4 2016
As of 31 Dec 2016 Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) had 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,594,528 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, Advisor Group, Inc., GEODE CAPITAL MANAGEMENT, LLC, RAYMOND JAMES & ASSOCIATES, BlackRock Fund Advisors, Manatuck Hill Partners, LLC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, BlackRock Institutional Trust Company, N.A., LADENBURG THALMANN FINANCIAL SERVICES INC., and WOLVERINE TRADING, LLC.
This table shows 37 institutional shareholders of the security as of 31 Dec 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.